• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY C CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY C CREATININE Back to Search Results
Model Number 07P9920
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/14/2020
Event Type  malfunction  
Manufacturer Narrative
There was no further patient information provided by the customer.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed falsely elevated creatinine on alinity c processing module for multiple patients.The results were provided: on (b)(6) 2020 sid (b)(6) creatinine=177 umol/l on (b)(6) 2020 repeated on another alinity =98 umol/l(% difference=81%) (laboratory reference range for men=63.6 to 110.5 umol/l and women=50.4 to 98.1 umol/l).There was no reported impact to patient management.
 
Manufacturer Narrative
An investigation was performed for the customer issue and included a review of the complaint text, troubleshooting, a search for similar complaints, instrument service history review, and a review of product labeling.A review of tickets was performed for alinity creatinine reagent lot number 82385un19.The ticket search found no complaints similar to this issue.A review of tracking and trending did not identify any trends for the complaint issue.Return testing was not completed as returns were not available.A review of the manufacturing documentation did not identify any issues associated with the complaint issue.A review of labeling concluded that the issue is sufficiently addressed.Based on the investigation no systemic issue or deficiency of the creatinine assay lot number 82385un19 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY C CREATININE
Type of Device
CREATININE
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key10203144
MDR Text Key222187681
Report Number3002809144-2020-00533
Device Sequence Number1
Product Code CGX
UDI-Device Identifier00380740135102
UDI-Public00380740135102
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 07/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/04/2021
Device Model Number07P9920
Device Catalogue Number07P99-20
Device Lot Number82385UN19
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/02/2020
Initial Date FDA Received06/26/2020
Supplement Dates Manufacturer Received07/06/2020
Supplement Dates FDA Received07/08/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALINITY C PROCESSING MODULE; ALINITY C PROCESSING MODULE; LIST # 03R67-01, SERIAL # (B)(6); LIST # 03R67-01, SERIAL # (B)(6)
-
-